Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $4.33 USD
Change Today -0.01 / -0.23%
Volume 2.7M
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert E. Hoffman CPA

Chief Financial Officer, Principal Accounting Officer and Senior Vice President of Finance , Arena Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 26 board members in 3 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Robert E. Hoffman, CPA, has been the Chief Financial Officer of Arena Pharmaceuticals, Inc. since June 2012 and has been its Principal Accounting Officer since June 15, 2012. Mr. Hoffman has been Senior Vice President of Finance at Arena Pharmaceuticals, Inc. since June 2012. He has over 20 years of finance and accounting experience. Mr. Hoffman served as the Chief Financial Officer of Polaris Pharmaceuticals, Inc. (a/k/a Polaris Group) from March 2011 to August ...

Read Full Background

Corporate Headquarters*

6154 Nancy Ridge Drive
San Diego, California 92121

United States

Phone: 858-453-7200
Fax: 858-453-7210

Board Members Memberships*

Director, Chairman of Audit Committee and Member of Nominating & Governance Committee
Director and Member of Compensation Committee


St. Bonaventure University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$360,000

Stock Options*

Restricted Stock Awards$710,400
All Other Compensation$16,041
Exercised Options71,250
Exercised Options Value$456,165
Exercisable Options62,500
Exercisable Options Value$218,500
Unexercisable Options411,250
Unexercisable Options Value$1,320,350
Total Value of Options$1,995,015
Total Number of Options545,000

Total Compensation*

Total Annual Cash Compensation$524,541
Total Short Term Compensation$360,000
Other Long Term Compensation$726,441
Total Calculated Compensation$1,470,315
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARNA:US $4.33 USD -0.01


Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
Raul R. Rodriguez Chief Executive Officer, President and Director
Rigel Pharmaceuticals, Inc.
Seth H. Z. Fischer Chief Executive Officer, Chief Commercial Officer and Director
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARENA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at